Skip to main content

Table 5 5-year survival rates calculated by cross validation

From: Gene expression of PMP22 is an independent prognostic factor for disease-free and overall survival in breast cancer patients

 

5-year DFS rate

5-year OS rate

Quartile (Risk Scores)

with PMP22

without PMP22

with PMP22

without PMP22

1 (lowest risk)

88%

87%

98%

91%

2 (intermediate low risk)

63%

68%

87%

91%

3 (intermediate high risk)

59%

48%

74%

78%

4 (highest risk)

41%

47%

62%

59%

Rate difference (lowest to highest risk)

47%

40%

36%

32%

 

p = 0.001

p<0.0001